Table 1.
Inactivated influenza vaccines available in the United States
| Vaccine type | Trade name | Manufacturer | Package type |
| Inactived influenza vaccine trivalent (IIV3) | Afluria | CSL Limited | Prefilled syringe or Multidose vial |
| Fluarix | GlaxoSmithKline | Prefilled syringe | |
| Flucelvax | Novartis | Prefilled syringe | |
| FluLaval | ID Biomedical Corp | Multidose vial | |
| Fluvirin | Novartis | Prefilled syringe or Multidose vial | |
| Fluzone | Sanofi Pasteur | Prefilled syringe or Multidose vial | |
| Fluzone intradermala | Sanofi Pasteur | Prefilled injection system | |
| Inactivated influenza vaccine trivalent (IIV3) high dose | Fluzone high dose | Sanofi Pasteur | Prefilled syringe |
| Inactivated influenza vaccine quadrivalent (IIV4) | Fluarix quadrivalent | GlaxoSmithKline | Prefilled syringe |
| Fluzone quadrivalent | Sanofi Pasteur | Prefilled syringe or Single-dose vial | |
| Recombinant influenza vaccine trivalent (RIV3) | FluBlok | Protein Sciences | Single-dose vial |
a
Intradermal vaccine is only indicated for individuals who are 18 to 64 years of age. No studies have evaluated efficacy for reducing cardiovascular risk.
Adapted from Centers for Disease Control and Prevention (CDC). Summary recommendations: Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices—(ACIP)—United States, 2013-14. http://www.cdc.gov/flu/professionals/acip/2013-summary-recommendations.htm. Accessed August 25, 2013.